Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
JP Sevilla, Daria Burnes, Rehab Zakaria El Saie, Hammam Haridy, Matt Wasserman, Sarah Pugh, Johnna Perdrizet & David Bloom. (2022) Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Salini Mohanty, Tianyan Hu, GyongSeon Yang, Tsz K Khan, Kwame Owusu-Edusei & Isaya Sukarom. (2022) Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in Korea and Hong Kong. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Bruce Cm Wang, Nathorn Chaiyakunapruk, Shuiqing Zhu, Joseph B. Babigumira, Wesley Furnback, Ramaa Chitale, Amgad Gamil, Kun Zhao & Matt Wasserman. (2022) A systematic literature review of economic evaluations of pneumococcal conjugate vaccines in east and southeast Asia (2006-2019). Expert Review of Vaccines 21:7, pages 885-898.
Read now
Read now
Johnna Perdrizet, Raymond A. Farkouh, Emily K. Horn, Kyla Hayford, Heather L. Sings & Matt D. Wasserman. (2022) The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines. Expert Review of Vaccines 21:4, pages 499-511.
Read now
Read now
Hye-Young Kim, Seong-Beom Park, Eun-Sil Kang, Sang-Min Lee, Hyun-Jin Kim & Matt Wasserman. (2021) Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea. Human Vaccines & Immunotherapeutics 17:3, pages 909-918.
Read now
Read now
Suthira Taychakhoonavudh, Woralak Chumchujan, Raymond Hutubessy & Nathorn Chaiyakunapruk. (2020) Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries. Human Vaccines & Immunotherapeutics 16:7, pages 1728-1737.
Read now
Read now
Asrul Akmal Shafie, Norazah Ahmad, Jerusha Naidoo, Chee Yoong Foo, Callix Wong, Sarah Pugh & Kah Kee Tan. (2020) Estimating the population health and economic impacts of introducing a pneumococcal conjugate vaccine in Malaysia- an economic evaluation. Human Vaccines & Immunotherapeutics 16:7, pages 1719-1727.
Read now
Read now
Raul Isturiz, Heather L. Sings, Betsy Hilton, Adriano Arguedas, Ralf-Rene Reinert, Bradford Gessner & Luis Jodar. (2018) Response to Mungall et al. letter to the editor on Streptococcus pneumoniae serotype 19A: worldwide epidemiology. Expert review of vaccines 2017;16(10):1007–27. Expert Review of Vaccines 17:8, pages 669-671.
Read now
Read now
Hua Zhou, Jinchun He, Bin Wu & Datian Che. (2018) Cost-effectiveness analysis of routine 13-valent pneumococcal conjugate vaccinations in Chinese infants. Human Vaccines & Immunotherapeutics 14:6, pages 1444-1452.
Read now
Read now
Guijun Ning, Zundong Yin, Yixing Li, Huaqing Wang & Weizhong Yang. (2018) Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China. Human Vaccines & Immunotherapeutics 14:1, pages 36-44.
Read now
Read now
Lijoy Varghese, Bruce Mungall, Xu-Hao Zhang & Bernard Hoet. (2016) Response to Wu et al. — Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong. Human Vaccines & Immunotherapeutics 12:10, pages 2675-2680.
Read now
Read now
Articles from other publishers (20)
Wanatpreeya Phongsamart, Kristen E. Allen, Warunee Punpanich Vandepitte, Chonnamet Techasaensiri, Pope Kosalaraksa, Kamolwish Laoprasopwattana, Puttichart Khantee, Songkiat Udompornwattana, Detchvijitr Suwanpakdee, Tavitiya Sudjaritruk, Thanyawee Puthanakit, Suvaporn Anugulruengkitt, Jo Southern, Mark A. Fletcher, Eileen M. Dunne, Ruangwit Thamaree, Graciela Morales, Kulkanya Chokephaibulkit & Tawee Chotpitayasunondh. (2023) Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational study. IJID Regions 8, pages 49-57.
Crossref
Crossref
Kris Doggen, Albert Jan van Hoek & Jeroen Luyten. (2023) Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella. PharmacoEconomics 41:5, pages 481-497.
Crossref
Crossref
M. Sakil Syeed, Priyanka Ghule, Lan M. Le, Sajesh K. Veettil, Emily K. Horn, Johnna Perdrizet, Matt Wasserman, Ammarin Thakkinstian & Nathorn Chaiyakunapruk. (2023) Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies. Value in Health 26:4, pages 598-611.
Crossref
Crossref
Siyu Ma, Tara A. Lavelle, Daniel A. Ollendorf & Pei-Jung Lin. (2022) Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries. Applied Health Economics and Health Policy 20:3, pages 395-404.
Crossref
Crossref
Yawen Jiang, Dan Cai & Si Shi. (2022) Economic evaluations of inactivated COVID-19 vaccines in six Western Pacific and South East Asian countries and regions: A modeling study. Infectious Disease Modelling 7:1, pages 109-121.
Crossref
Crossref
Alex J. J. Lister, Cheng Foh Le, Eddy Seong Guan Cheah, Mohd Nasir Mohd Desa, David W. Cleary & Stuart C. Clarke. (2021) Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysis. Pneumonia 13:1.
Crossref
Crossref
Enrique Chacon-Cruz & Erika Z Lopatynsky. (2021) Continuous Effectiveness of Pneumococcal 13-Valent Conjugate Vaccine on Pediatric Pneumococcal Otomastoiditis: Results of 15 Years of Active/Prospective Surveillance in a Mexican Hospital on the Mexico-US Border. Cureus.
Crossref
Crossref
Auliya A. Suwantika, Neily Zakiyah, Rizky Abdulah, Vensya Sitohang, Gertrudis Tandy, Atiek Anartati, Tetrawindu Hidayatullah, Putri Herliana & Sri R. Hadinegoro. (2021) Cost-Effectiveness and Budget Impact Analyses of Pneumococcal Vaccination in Indonesia. Journal of Environmental and Public Health 2021, pages 1-11.
Crossref
Crossref
Amgad Gamil, Kulkanya Chokephaibulkit, Wanatpreeya Phongsamart, Chonnamet Techasaensiri, Barameht Piralam & Ruangwit Thamaree. (2021) Pneumococcal disease in Thailand. International Journal of Infectious Diseases 102, pages 429-436.
Crossref
Crossref
Chun-Yi Lu, Ching-Hu Chung, Li-Min Huang, Eliza Kruger, Seng-Chuen Tan, Xu-Hao Zhang & Nan-Chang Chiu. (2020) Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan. Cost Effectiveness and Resource Allocation 18:1.
Crossref
Crossref
Ana Isabel Valdivielso Martínez, Jose Miguel Ramos Fernández, Javier Pérez Frías & David Moreno Pérez. (2020) Influence of pneumococcal vaccination on the hospitalization of healthy pediatric patients due to typical Community-Acquired Pneumonia. International Journal of Infectious Diseases 98, pages 194-199.
Crossref
Crossref
Neily Zakiyah, Widya N. Insani, Auliya A. Suwantika, Jurjen van der Schans & Maarten J. Postma. (2020) Pneumococcal Vaccination for Children in Asian Countries: A Systematic Review of Economic Evaluation Studies. Vaccines 8:3, pages 426.
Crossref
Crossref
Ku Nurhasni Ku Abd Rahim, Hanin Farhana Kamaruzaman, Maznah Dahlui & Sharifa Ezat Wan Puteh. (2020) From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia: A Systematic Review. Value in Health Regional Issues 21, pages 91-99.
Crossref
Crossref
Tinevimbo Shiri, Kamran Khan, Katherine Keaney, Geetanjali Mukherjee, Noel D. McCarthy & Stavros Petrou. (2019) Pneumococcal Disease: A Systematic Review of Health Utilities, Resource Use, Costs, and Economic Evaluations of Interventions. Value in Health 22:11, pages 1329-1344.
Crossref
Crossref
Alen Marijam, Jan Olbrecht, Alev Ozakay, Volkan Eken & Kinga Meszaros. (2019) Cost-Effectiveness Comparison of Pneumococcal Conjugate Vaccines in Turkish Children. Value in Health Regional Issues 19, pages 34-44.
Crossref
Crossref
Piyameth Dilokthornsakul, Kirati Kengkla, Surasak Saokaew, Unchalee Permsuwan, Chonnamet Techasaensiri, Tawee Chotpitayasunondh & Nathorn Chaiyakunapruk. (2019) An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand. Vaccine 37:32, pages 4551-4560.
Crossref
Crossref
Kinley Dorji, Sonam Phuntsho, Pempa, Suthasinee Kumluang, Sarayuth Khuntha, Wantanee Kulpeng, Sneha Rajbhandari & Yot Teerawattananon. (2018) Towards the introduction of pneumococcal conjugate vaccines in Bhutan: A cost-utility analysis to determine the optimal policy option. Vaccine 36:13, pages 1757-1765.
Crossref
Crossref
Xiao Jun Wang, Ashwini Saha & Xu-Hao Zhang. (2017) Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia. Cost Effectiveness and Resource Allocation 15:1.
Crossref
Crossref
Carlos K.H. Wong, Qiuyan Liao, Vivian Y.W. Guo, Yiqiao Xin & Cindy L.K. Lam. (2017) Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review. Vaccine 35:24, pages 3153-3161.
Crossref
Crossref
T.K.P. Nguyen, T.H. Tran, C.L. Roberts, S.M. Graham & B.J. Marais. (2017) Child pneumonia ? focus on the Western Pacific Region. Paediatric Respiratory Reviews 21, pages 102-110.
Crossref
Crossref